Skip to content
Toggle main navigation
More
Open dropdown to see remaining menu items
Log in
Reserpine has potential to be repurposed as treatment for retinitis pigmentosa, studies suggest
Published on May 13, 2025
The drug was previously approved for high blood pressure in 1955.
Continue reading on website
Other news
PECAA Gives Celebrates 10th Anniversary With Record Donation to Orlando Nonprofit
May 13, 2025
BOCA RATON, Fla.—Professional Eye Care Associates of America (PECAA) members, strategic vendor partners, industry leaders and employees donated more than $41,000 to Orlando youth literacy program Page 15 during the 2025 PECAA Annual Meeting held in Orlando from April 9-11, 2025, the group announced. The donation marks the largest amount given to a recipient since the inception of the organization'
LumiThera announces top-line results from LIGHTSITE IIIB extension trial assessing the Valeda Light Delivery System
May 13, 2025
Valeda met the primary end point in the US LIGHTSIDE III trial, improving the best corrected visual acuity in patients for 24 months of >5 letters or equivalent to 1 line improvement on the eye chart, according to the company.
